ISRCTN42332281已完成不适用
Multicentre randomised, double-blind, controlled trial of laparoscopic versus open surgery for suspected appendicitis in adults
Sant'Orsola-Malpighi University Hospital Bologna (Italy)0 个研究点目标入组 386 人开始时间: 2005年10月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 386
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Adult (from 18 years old) patients with symptoms and signs of acute appendicitis, any gender.
排除标准
- •1. Refusing of informed consent
- •2. Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient)
- •3. Patients with contraindication to be operated with either LA (to be stated), or OA (to be stated) will be excluded from the study
- •4. American Society of Anaesthesiologists (ASA) grade IV or V
- •5. Not fluent Italian speakers
研究者
相似试验
未知
3 期
Multicenter, double-blind randomized, controlled study for the treatment of involutional osteoporosisJPRN-jRCT2080220084ONO PHARMACEUTICAL CO.,LTD.
未知
3 期
Multicenter, double-blind randomized, controlled study for the treatment of involutional osteoporosisInvolutional osteoporosisJPRN-jRCT2080220085ONO PHARMACEUTICAL CO.,LTD.
进行中(未招募)
1 期
Randomized, controlled, double-blind multicenter safety study to evaluate the safety and immunogenicity of subcutaneous EPO HEXAL vs. ERYPO® in the treatment of anemia associated with chronic renal insufficiency in predialysis patientsEUCTR2007-001906-26-FRHEXAL Biotech ForschungsGmbH300
进行中(未招募)
不适用
Randomized, controlled, double-blind multicenter safety study to evaluate the safety and immunogenicity of subcutaneous EPO HEXAL vs. ERYPO® in the treatment of anemia associated with chronic renal insufficiency in predialysis patientsEUCTR2007-001906-26-ATHEXAL AG300
进行中(未招募)
不适用
Randomized, controlled, double-blind multicenter safety study to evaluate the safety and immunogenicity of subcutaneous EPO HEXAL vs. ERYPO® in the treatment of anemia associated with chronic renal insufficiency in predialysis patientsEUCTR2007-001906-26-BGHEXAL Biotech ForschungsGmbH300
